OB/GYN Clinical Alert
RSSArticles
-
Reducing Opioid Prescriptions Following Gynecologic Surgery
With sufficient institutional buy-in, appropriate patient education, and staff adherence to standardized postoperative prescribing practices, patients undergoing abdominal gynecologic surgery can leave the hospital safely and recover with low doses of opioid medications, or no opioid prescription at all.
-
Are We Prescribing Enough Emergency Contraception?
In this national sample of obstetrician-gynecologists, the majority (84%) reported offering at least one form of emergency contraception, with 80% offering the levonorgestrel pill, 18% offering ulipristal acetate, and 29% offering the copper intrauterine device.
-
The Utility of Nuchal Translucency Screening in the Era of Cell-Free Fetal DNA Testing
In this retrospective cohort study of 1,901 pregnant women between 11 weeks and 13 weeks six days of gestation who had a nuchal translucency (NT) screening for fetal aneuploidies and demonstrated NT measurements > 95th percentile, 47% of fetuses (894/1,901) had an NT between the 95th and 99th percentile and 53% (1,007/1,901) had an NT ≥ the 99th percentile. In addition, of the 43% of fetuses (814/1,901) with at least one abnormality (structural or genetic), 34% (279/814) would have been missed in the first trimester if only cell-free deoxyribonucleic acid was used for prenatal genetic screening.
-
Pap Smear Management: An Update on Recent Recommendations
Despite its current prevalence in the care of patients, the Pap smear has been used for less than 100 years. A major advancement in the field of screening came in the late 1970s and early 1980s with the identification that the human papilloma virus (HPV). Since the year 2000, there have been multiple progressive cycles of updates to both screening and management guidelines as the result of our rapidly evolving understanding of HPV.
-
A New Nonhormonal Vaginal Gel Contraceptive
In this single-arm, open-label, Phase III study of a novel vaginal pH regulator gel among 1,384 sexually active women aged 18 to 35 years, the seven-cycle cumulative pregnancy rate was 13.7% (95% confidence interval, 10.0% to 17.5%).
-
Is Universal Rescreening of Pregnant Women for Hepatitis C Cost-Effective?
In this cost-effectiveness analysis study, the authors assessed the cost effectiveness of offering hepatitis C virus (HCV) antenatal rescreening to U.S. women who previously were screened HCV negative in a prior pregnancy.
-
Body Mass Index and Safety of Postpartum Tubal Ligation
In a single-institution, retrospective review of 3,670 postpartum tubal ligations performed after vaginal delivery, there was no association between increasing body mass index and surgical morbidity.
-
Perinatal Mental Health During the COVID-19 Pandemic: The Role of the OB/GYN
The obstetrical effect of COVID-19 has received attention worldwide. However, data examining the psychological effect on women in the perinatal period still are emerging. Although there is little doubt that COVID-19 has increased depression and anxiety in many demographic groups, a small amount of existing literature begins to give us some insight into the incidence, risk factors, and protective factors for mental illness in perinatal women during the COVID-19 pandemic.
-
HPV Vaccination Reduces the Risk of Invasive Cervical Cancer
In this retrospective cohort study of women in Sweden, receipt of human papillomavirus vaccination prior to age 17 years was associated with an 88% decrease in cervical cancer, and vaccination at ages 17 to 30 years was associated with a 53% decrease in cervical cancer.
-
Female Caregivers May Delay Seeking Care for Pelvic Floor Disorders
One-third of patients presenting for urogynecologic subspecialty care are caregivers. Of these, women caring for an adult are more likely to delay seeking care for pelvic floor disorders.